Global Human Growth Hormone Drugs Market 2011-2015
TechNavio's analysts forecast the Global Human Growth Hormone Drug market to grow at a CAGR of 3 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in number of people suffering from growth hormone deficiency. The Global Human Growth Hormone Drug market has also been witnessing the use of human growth hormone for anti-ageing remedy. However, the reluctance of physicians to prescribe human growth hormone drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Human Growth Hormone Drug Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Growth Hormone Drug market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Novo Nordisk A/S, Pfizer Inc., Eli Lilly and Co. and Roche Holding Ltd.
Key questions answered in this report:
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
Table of Contents
Table of Contents:
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Novo Nordisk A/S
14.2 Pfizer Inc.
14.3 Eli Lilly and Co.
14.4 Roche Holding Ltd.
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Human Growth Hormone Drugs Market 2011-2015 (US$ billion)
Exhibit 2: Global Human Growth Hormone Drugs Market by Geographical Segmentation 2011
Exhibit 3: Global HGH Drugs Market by Vendor Segmentation 2011
Published April 16, 2012